ArticleBMC research notes2018

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients.

Hisato Shima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.